These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5469691)

  • 41. [Urinary metabolites of rifampicin].
    Sano M; Hakusui H
    Jpn J Antibiot; 1970 Aug; 23(4):416-20. PubMed ID: 5312793
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacokinetics and metabolism of rifampin in humans.
    Acocella G
    Rev Infect Dis; 1983; 5 Suppl 3():S428-32. PubMed ID: 6356276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is the purpose of liver function tests?
    Blann A
    Nurs Times; 2014 Feb 5-11; 110(6):17-9. PubMed ID: 24669469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Dynamics of the distribution of rifocin in patients with chronic tonsillitis at different methods of administration].
    Skurkovich GV; Vasina TA; Tolkacheva LI; Kilachitskaia VI
    Antibiotiki; 1970 Dec; 15(12):1117-20. PubMed ID: 4925642
    [No Abstract]   [Full Text] [Related]  

  • 45. [Study of blood concentrations of rifamycin in relation to the dose and method of administration].
    Daddi G; Garimoldi M; Perna G; Mazzola C; Cornia G; Scarpazza G
    G Ital Mal Torace; 1968; 22(6):341-8. PubMed ID: 5729886
    [No Abstract]   [Full Text] [Related]  

  • 46. [Metabolism of rifampicin in the human body (1st report)].
    Nakagawa H; Sunahara S
    Kekkaku; 1973 May; 48(5):167-76. PubMed ID: 4732656
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of hepatic reserve].
    Okumura M
    Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):770-3. PubMed ID: 6491447
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of liver function: the current situation.
    Van Thiel DH; Hassanein T
    J Okla State Med Assoc; 1995 Jan; 88(1):11-6. PubMed ID: 7897548
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Kinetic rate constant changes of Rifampicin and bilirubin serum levels following single and repeated administration of different per kg doses in humans].
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Arch Monaldi; 1970; 25(6):427-40. PubMed ID: 5514802
    [No Abstract]   [Full Text] [Related]  

  • 52. Buflomedil kinetics in patients with liver disease.
    Rey E; D'Athis P; Richard MO; Guerre J; Dorfman P; Bercoff E; Olive G
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):408-14. PubMed ID: 3759277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [20 min/5 min clearance index of bromosulfophenolphthalein. A simple test of hepatic function].
    Sotto Escobar A
    Rev Esp Enferm Apar Dig; 1986 Feb; 69(2):137-40. PubMed ID: 3704272
    [No Abstract]   [Full Text] [Related]  

  • 54. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
    Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
    Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Renal elimination of rifamycin SV by patients with renal disease].
    Bianchi Porro G; Timbal MT
    Antibiotica; 1967 Jun; 5(2):114-27. PubMed ID: 5609361
    [No Abstract]   [Full Text] [Related]  

  • 56. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
    Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
    Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clearance of bromosulphthalein from plasma as a measure of hepatic function in normal horses and in horses with liver disease.
    West HJ
    Res Vet Sci; 1988 May; 44(3):343-8. PubMed ID: 3406531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of hepatic bilirubin and paranitrophenol glucuronyl transferase activity. 3. Effect of rifampicin alone or associated with streptomycin and isoniazid in man].
    Hakim J; Feldmann G; Boivin P; Troube H; Boucherot J; Penaud J; Guibout P; Kreis B
    Pathol Biol (Paris); 1973 Mar; 21(3):255-63. PubMed ID: 4574487
    [No Abstract]   [Full Text] [Related]  

  • 59. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 60. Prescribing in patients with abnormal liver function tests.
    Smith E; Desmond P
    Aust Fam Physician; 2013; 42(1-2):30-3. PubMed ID: 23529456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.